Patents Assigned to Nirsum Laboratories, Inc.
  • Opioid receptor antagonist prodrugs
    Patent number: 10544154
    Abstract: Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: January 28, 2020
    Assignee: Nirsum Laboratories, Inc.
    Inventors: Michael W. Tusche, Nikej Shah
  • Opioid receptor antagonist prodrugs
    Patent number: 10538531
    Abstract: Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: January 21, 2020
    Assignee: Nirsum Laboratories, Inc.
    Inventors: Michael W. Tusche, Nikej Shah
  • Opioid receptor antagonist prodrugs
    Patent number: 10533015
    Abstract: Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: January 14, 2020
    Assignee: Nirsum Laboratories, Inc.
    Inventors: Michael W. Tusche, Nikej Shah
  • Opioid receptor antagonist prodrugs
    Patent number: 10525055
    Abstract: Provided herein are prodrugs of opioid receptor antagonists such as nalmefene and naltrexone, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of behavioral disorders.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: January 7, 2020
    Assignee: Nirsum Laboratories, Inc.
    Inventors: Michael W. Tusche, Nikej Shah, Mingping Ding, Qiang Han, Liangliang Ji